These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 4816171)

  • 21. Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow.
    Buckley RH; Lucas ZJ; Hattler BG; Zmijewski CM; Amos DB
    Clin Exp Immunol; 1968 Feb; 3(2):153-69. PubMed ID: 4171049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermatophytosis in patients with chronic mucocutaneous candidiasis.
    Shama SK; Kirkpatrick CH
    J Am Acad Dermatol; 1980 Apr; 2(4):285-94. PubMed ID: 7364986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Classification of chronic mucocutaneous candidiasis with observations on the clinical picture and its therapy].
    Higgs JM; Wells RS
    Hautarzt; 1974 Apr; 25(4):159-65. PubMed ID: 4603392
    [No Abstract]   [Full Text] [Related]  

  • 24. [Chronic mucocutaneous candidiasis. Treatment with immunotherapy and a new antifungal agent].
    Lorente F; Fontán G; Soto Melo J; García-Rodríguez MC; Ojeda JA
    Rev Clin Esp; 1977 Apr; 145(2):139-43. PubMed ID: 860064
    [No Abstract]   [Full Text] [Related]  

  • 25. Topical treatment of inflammatory dermatoses and cutaneous candidiasis with a new cortico-steroid -antibiotic combination: halcinonide-neomycin-amphotericin.
    Reyes-Javier P
    Br J Clin Pract; 1977 Apr; 31(4):33-5, 39. PubMed ID: 326284
    [No Abstract]   [Full Text] [Related]  

  • 26. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study.
    Mobacken H; Hanson LA; Lindholm L; Ljunggren C
    Acta Derm Venereol; 1980; 60(1):51-5. PubMed ID: 6153834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice].
    Moulias R; Goust JM; Reinert P; Fournel JJ; Deville-Chabrolle A; Duoung N; Muller-Berat CN; Berthaux P
    Nouv Presse Med; 1973 May; 2(20):1341-4. PubMed ID: 4357775
    [No Abstract]   [Full Text] [Related]  

  • 28. [Transfer factor of cellular immunity. Preliminary therapeutic trials during specific immunologic deficiencies of an antigen in human clinical practice].
    Moulias R; Goust JM; Reinert P; Fournel JJ; Deville-Chabrolle A; Duong N; Muller-Berat CN; Berthaux P
    Nouv Presse Med; 1973 May; 2(20):1341-4. PubMed ID: 4351886
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic mucocutaneous candidiasis: a model for the investigation of cell mediated immunity.
    Holt PJ; Higgs JM; Munro J; Valdimarsson H
    Br J Clin Pract; 1972 Jul; 26(7):331-6. PubMed ID: 5074179
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chronic candidiasis in children and adolescents].
    Moroz EIa; Sheklakov ND; Leshchenko VM
    Vestn Dermatol Venerol; 1970 Aug; 44(8):45-50. PubMed ID: 5494193
    [No Abstract]   [Full Text] [Related]  

  • 31. Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.
    Edwards JE; Lehrer RI; Stiehm ER; Fischer TJ; Young LS
    Ann Intern Med; 1978 Jul; 89(1):91-106. PubMed ID: 352220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Topical clotrimazole treatment of chronic mucocutaneous candidiasis.
    Pazin GJ; Nagel JE; Friday GA; Fireman P
    J Pediatr; 1979 Feb; 94(2):322-4. PubMed ID: 762637
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of chronic mucocutaneous candidiasis of children (Candida Granuloma) with Clotrimazole.
    Meinhof W; Günther D
    Arch Dermatol Forsch; 1972; 242(3):293-308. PubMed ID: 4337938
    [No Abstract]   [Full Text] [Related]  

  • 34. Suppression of cellular immune responses following transfer factor: report of a case.
    Kirkpatrick CH; Gallin JI
    Cell Immunol; 1975 Feb; 15(2):470-4. PubMed ID: 1089483
    [No Abstract]   [Full Text] [Related]  

  • 35. [Candida granuloma and its treatment in simultaneous staphylococcal infections].
    Lange FC; Pevny I; Staib F
    Dtsch Med Wochenschr; 1967 Feb; 92(5):192-8. PubMed ID: 6017854
    [No Abstract]   [Full Text] [Related]  

  • 36. Verrucae vulgaris rejection. A preliminary study of contact dermatitis and cellular immunity response.
    Greenberg JH; Smith TL; Katz RM
    Arch Dermatol; 1973 Apr; 107(4):580-2. PubMed ID: 4697688
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial: Chronic mucocutaneous candidiasis.
    Br Med J; 1973 Dec; 4(5891):504. PubMed ID: 4758483
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic muco-cutaneous candidiasis: new approaches to treatment.
    Higgs JM; Wells RS
    Br J Dermatol; 1973 Aug; 89(2):179-90. PubMed ID: 4580212
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunologic features of chronic granulomatous mucocutaneous candidiasis before and after treatment with transfer factor.
    Horsmanheimo M; Krohn K; Virolainen M; Blomqvist K
    Arch Dermatol; 1979 Feb; 115(2):180-4. PubMed ID: 426525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monilial granuloma (Candida).
    Wachs GN
    Arch Dermatol; 1970 Jan; 101(1):118-9. PubMed ID: 5416789
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.